In today's article, Indo Search Director Josh Craven looks at what is new in MedTech and HealthTech this July.
The effect delaying re-joining Horizon can have on UK Medtech.
James Sheppard, managing director of UK & Ireland at Kadans Science Partner, discusses the impact of the UK delaying re-joining the Horizon Europe programme, a key EU funding program for research and innovation. He emphasizes that Horizon Europe offers significant opportunities for collaborative R&D with researchers, innovators, and businesses worldwide. Read more
OrganOx raises £25m ahead of future IPO.
Oxford-based OrganOx secures £25 million in funding for expanding its commercial footprint, particularly in the United States. The funding will support strategic growth areas and the expansion of their customer-facing team. Read more
Recommendations to improve UK’s competitiveness in key industries, including MedTech.
Academic experts from Imperial College London propose recommendations to enhance the UK's competitiveness in Biopharmaceuticals, Medtech, and Telecommunications industries. The report identifies missed opportunities that could further boost the performance of these sectors. Read more
Skin Analytics awarded funding to scale AI tech that detects skin cancer.
London-based medical technology company Skin Analytics receives funding from the NHS Cancer Programme Innovation open call to scale its AI technology for detecting skin cancer. The aim is to provide faster and more convenient access to skin cancer assessments, improving outcomes for patients diagnosed with cancer. Read more
Graduate inventor of incubator saving babies' lives in Ukraine wins The Princess Royal Silver Medal.
James Roberts, a graduate from Loughborough, is honoured with The Princess Royal Silver Medal from the Royal Academy of Engineering for inventing a neonatal incubator that has helped babies thrive in NHS hospitals and war-torn Ukraine. The innovative incubator is designed, developed, and manufactured in Britain. Read more.
UK Health Officials Embrace the Power of AI in Healthcare.
The UK government invests significantly in AI technology for healthcare, particularly in AI diagnostic tools. £21 million is allocated to the National Health Service (NHS) to support the development of AI imaging and support tools for faster diagnosis of cancer, stroke, and heart conditions. The NHS has invested £123 million in AI technologies for various medical applications. Read more.
MHRA Includes UKCA Marking Updates In New IVD Guidance For Great Britain.
The Medicines and Healthcare Products Regulatory Agency (MHRA) issues new guidance on selling and supplying in vitro diagnostics (IVDs) in Great Britain. The guidance includes updates on UKCA marking, ensuring compliance with regulations in the medical technology sector. Read more